A rare case of metastatic involvement of the bone marrow in a patient with medulloblastoma

Cover Page

Cite item

Full Text

Abstract

Extraneural metastasis from primary brain tumors is an extremely rare occurrence. The majority of such cases described in the literature are medulloblastoma relapses. In this article, we report a case of relapse in a patient with medulloblastoma with the metastatic involvement of the bone marrow two years after successful treatment for the primary tumor. The patient's parents gave consent to the use of their child's data, including photographs, for research purposes and in publications.

About the authors

T. V. Konyukhova

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Author for correspondence.
Email: tkonuhova@mail.ru
ORCID iD: 0000-0001-6271-7435

Tatyana V. Konyukhova - MD in Clinical Laboratory Medicine at the Clinical and Diagnostic Laboratory.

1 Samory Mashela St., Moscow 117997

Russian Federation

I. G. Vilesova

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0001-6296-4305

Moscow

Russian Federation

E. A. Salnikova

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0002-9846-2793

Moscow

Russian Federation

A. V. Artemov

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0002-0628-1726

Moscow

Russian Federation

A. P. Shcherbakov

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0001-8129-0545

Moscow

Russian Federation

L. I. Papusha

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0001-7750-5216

Moscow

Russian Federation

References

  1. Menyhárt O, Győrffy B. Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches. Cancer Metastasis Rev. 2020 Mar; 39(1):211-233. doi: 10.1007/s10555-020-09854-1. PMID: 31970590; PMCID: PMC7098941.
  2. Prados MD. Current Strategies for Management of Medulloblastoma. Diagnostics (Basel). 2023 Aug 8;13(16):2622. doi: 10.3390/diagnostics13162622. PMID: 37627881; PMCID: PMC10453892.
  3. Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106. PMID: 34185076; PMCID: PMC8328013.
  4. Paulino A.C. (2012) Extraneural Metastasis in Medulloblastoma. In: Hayat M. (eds) Tumors of the Central Nervous System, Volume 8. Tumors of the Central Nervous System, vol 8. Springer, Dordrecht. doi: 10.1007/978-94-007-4213-0_7
  5. Rickert CH. Extraneural metastases of paediatric brain tumours. Acta Neuropathol. 2003 Apr;105(4):309-27. doi: 10.1007/s00401-002-0666-x. Epub 2003 Jan 21. PMID: 12624784.
  6. Mazloom A, Zangeneh AH, Paulino AC. Prognostic factors after extraneural metastasis of medulloblastoma. Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):72-8. doi: 10.1016/j.ijrobp.2009.07.1729. Epub 2010 Feb 3. PMID: 20133080.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2025 Konyukhova T.V., Vilesova I.G., Salnikova E.A., Artemov A.V., Shcherbakov A.P., Papusha L.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.